Designing a Shorter Vertical Leg for Sanitary Steam Traps - - BioPharm International

ADVERTISEMENT

Designing a Shorter Vertical Leg for Sanitary Steam Traps


BioPharm International
Volume 19, Issue 9


An Orifice Trap is Not a Steam Trap
It is difficult to calculate a precise sub-cool temperature. Sub-cool is the difference in temperature that causes the bellows to actuate. If the load temporarily exceeds the capacity of the trap, backup occurs. The trap opens, but the temperature continues to drop until the cycle is exhausted. The average sub-cool for the –B2 bellows was 2.3 F for 20 psig, 1.75 F for 25 psig, 1.45 F for 30 psig, and 1.0 F for 35 psig. The –B bellows has an average sub-cool of 2.0 F. The maximum sub-cool for the B bellows is 3.4 F for 20 psig and 1.5 F for 35 psig. The maximum sub-cool for the –A bellows is 5.3 F.

CONCLUSION

The Nicholson Steam Trap Company's model CDS steam trap with a type –B bellows has proven itself in laboratory tests to be sensitive enough to maintain backup below 6 in. for loads ranging from 1 to 27 lb/h, encountered during SIP maintenance of vessels ranging from 20 to 40,000 L.

These laboratory results are encouraging and the next step is to repeat these results in a field setting. Field data will offer a high degree of assurance of the trap's performance, so facilities can be designed around steam traps with a 6 in. backup.

George W. Page, Jr., is director of engineering for Spence Engineering Co., Inc., 150 Coldenham Road, Walden, NY 12586; 845.778.5566, fax: 914.778.1930;

Richard Kral is a lead process engineer at Jacobs, BioPharm Office, Three Tower Bridge, Two Ash Street, Conshohocken, PA 19428, 610.832.2625, fax 610.238.1100,

REFERENCES

1. Fluid Controls Institute. FCI 87-1-2004, Classification and Operating Principles of Steam Traps. Cleveland OH; 2004.

2. Lydersen BK, D'Elia NA, Nelson KL, Oakley T. Bioprocess Engineering: Systems, Equipment, and Facilities. Hoboken NJ: John Wiley & Sons, Inc.; 1994, p. 515.

3. Fluid Controls Institute. Tech Sheet #ST 101. Some Usage Consequences with Orifice Drain Devices (Valuable Design Considerations for Engineers, Designers, and Steam Users). Cleveland OH; 2003 August 20.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here